Loading clinical trials…
Loading clinical trials…
Clinical trials
Studies registered on ClinicalTrials.gov whose conditions were reconciled to the cancer taxonomy. Status and phase are as posted by the registrant.
843 studies match
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT06767436 | A Multi-center Real-world Efficacy and Safety of Trastuzumab-deruxtecan in Advanced Gastric Cancer | recruiting | — | 300 | Yonsei UniversityOTHER | 1 | Jan 9, 2025 | clinicaltrials |
| NCT06767449 | Zolbetuximab Claudin18.2 Positive, HER2 Negative, Advanced Gastric Cancer(Zolbetuximab) | recruiting | — | 80 | Yonsei UniversityOTHER | 1 | Jan 9, 2025 |
| NCT06690112 | Pilot Study for High Output Drainage Removal After Gastrectomy | recruiting | N/A | 60 | Gangnam Severance HospitalOTHER | 1 | Jan 8, 2025 | clinicaltrials |
| NCT04819243 | PALbociclib Endocrine Therapy Followed by Talazo Vs. Talazoz-Atezo Study(Young-PALETTA) | recruiting | Phase 2 | 178 | Samsung Medical CenterOTHER | 1 | Jan 3, 2025 | clinicaltrials |
| NCT04214990 | Aspirin Use for Gastric Cancer Prevention in the Early Gastric Cancer Patients(EASTERN) | recruiting | Phase 3 | 1,700 | National Cancer Center, KoreaOTHER_GOV | 1 | Dec 27, 2024 | clinicaltrials |
| NCT04890171 | Comparison of Endoscopic Resection and Surgery for Early Gastric Cancer With Undifferentiated Histological Type(ERASE-GC) | recruiting | N/A | 708 | National Cancer Center, KoreaOTHER_GOV | 1 | Dec 27, 2024 | clinicaltrials |
| NCT05877430 | Safety, Tolerability, and Preliminary Efficacy of CJRB-101 With Pembrolizumab in Subjects With Selected Types of Advanced or Metastatic Cancer | recruiting | Phase 1 / Phase 2 | 160 | CJ Bioscience, Inc.INDUSTRY | 2 | Dec 20, 2024 | clinicaltrials |
| NCT05882292 | c-MET Inhibitor in Advanced Solid Tumors With c-MET Gene Aberration | recruiting | Phase 2 | 20 | Yonsei UniversityOTHER | 1 | Dec 20, 2024 | clinicaltrials |
| NCT06737250 | NB02 (Poseltinib) Combined Rituximab and Lenalidomide in R/R PCNSL(POTENTIAL-P) | recruiting | Phase 2 | 33 | NOBO MedicineINDUSTRY | 1 | Dec 17, 2024 | clinicaltrials |
| NCT06698887 | A Study to Evaluate the Long-Term Safety of Idecabtagene Vicleucel Treatment in Adults With Newly Diagnosed Multiple Myeloma in Korea | recruiting | — | 15 | Bristol-Myers SquibbINDUSTRY | 1 | Dec 13, 2024 | clinicaltrials |
| NCT06729684 | Development and Validation of a Personalized Digital Healthcare Model for Managing Side Effects in Breast Cancer Survivors | recruiting | N/A | 72 | Samsung Medical CenterOTHER | 1 | Dec 11, 2024 | clinicaltrials |
| NCT05733156 | Abscopal Effect from the Low-dose Radiotherapy in Polymetastatic Cancer Patients Receiving Stereotactic Radiotherapy(KROG22-11) | recruiting | N/A | 52 | Soonchunhyang University HospitalOTHER | 1 | Dec 10, 2024 | clinicaltrials |
| NCT05254197 | SeOuL cOhort of Brain Tumor MONitoring Study (SOLOMON)(SOLOMON) | recruiting | — | 3,000 | Seoul National University HospitalOTHER | 1 | Dec 3, 2024 | clinicaltrials |
| NCT05453682 | Hypofractionated IMRT With Concurrent Chemotherapy in Muscle-invasive Bladder Cancer (HIRACUM)(HIRACOM) | recruiting | N/A | 53 | Samsung Medical CenterOTHER | 1 | Dec 2, 2024 | clinicaltrials |
| NCT05440149 | The Postoperative Radiotherapy in N1 Breast Cancer Patients(PORT-N1) | recruiting | Phase 3 | 1,106 | Seoul National University HospitalOTHER | 1 | Nov 29, 2024 | clinicaltrials |
| NCT06075199 | Intestinal Metaplasia Cohort for Gastric Cancer Prediction | recruiting | — | 1,000 | Seoul National University HospitalOTHER | 1 | Nov 29, 2024 | clinicaltrials |
| NCT05529940 | NeoFOL-R Trial (Perioperative Versus Adjuvnat FOLFIRINOX in Resectable Pancreatic Cancer) | recruiting | Phase 3 | 609 | Seoul National University HospitalOTHER | 1 | Nov 27, 2024 | clinicaltrials |
| NCT05640830 | Trastuzumab, Bevacizumab with Paclitaxel for HER2-positive Gastric Cancer in a Second-line Therapy(TREAZURE) | recruiting | Phase 1 / Phase 2 | 47 | Kangbuk Samsung HospitalOTHER | 1 | Nov 26, 2024 | clinicaltrials |
| NCT03438474 | Endometrial Cancer Lymphadenectomy Trial(ECLAT) | recruiting | N/A | 640 | Philipps University MarburgOTHER | 3 | Nov 25, 2024 | clinicaltrials |
| NCT05824975 | A Study to Evaluate the Safety and Therapeutic Activity of GI-102 As a Single Agent and in Combination with Conventional Anti-cancer Drugs, Pembrolizumab or Trastuzumab Deruxtecan(T-DXd) in Patients with Advanced Solid Tumors (KEYNOTE-G08) | recruiting | Phase 1 / Phase 2 | 358 | GI Innovation, Inc.INDUSTRY | 2 | Nov 25, 2024 | clinicaltrials |
| NCT05072041 | Safety and Efficacy of Degradable Microsphere in Transcatheter Arterial Chemoembolization for Hepatocellular Carcinoma | recruiting | N/A | 150 | Next Biomedical Co., Ltd.INDUSTRY | 1 | Nov 14, 2024 | clinicaltrials |
| NCT06677944 | Preoperative Partial Breast Irradiation in Early-Stage Breast Cancer | recruiting | Phase 2 | 47 | Yonsei UniversityOTHER | 1 | Nov 7, 2024 | clinicaltrials |
| NCT05254171 | Study of Nab-Paclitaxel and Gemcitabine With or Without SBP-101 in Pancreatic Cancer(ASPIRE) | recruiting | Phase 2 / Phase 3 | 600 | Panbela Therapeutics, Inc.INDUSTRY | 10 | Nov 6, 2024 | clinicaltrials |
| NCT06073769 | A Post-Marketing Surveillance Study to Assess the Safety of Oral Azacitidine Maintenance Therapy in Korean Patients With Acute Myeloid Leukemia | recruiting | — | 154 | Bristol-Myers SquibbINDUSTRY | 1 | Nov 6, 2024 | clinicaltrials |
| NCT06595108 | Atezolizumab and BEvacizumab With STereotactic Body Radiotherapy for Advanced Hepatocellular Carcinoma(A-BEST) | recruiting | N/A | 33 | Yonsei UniversityOTHER | 1 | Nov 1, 2024 | clinicaltrials |
| NCT06395935 | Wecare Study in Gastric Cancer Survivors | recruiting | N/A | 88 | Gyeongsang National University HospitalOTHER | 1 | Oct 15, 2024 | clinicaltrials |
| NCT05629611 | Efficacy and Safety Evaluation of Vi-sealer | recruiting | N/A | 280 | Hyun ParkOTHER | 1 | Oct 1, 2024 | clinicaltrials |
| NCT06598293 | Routine Electronic Patient-reported Outcome Measures During and After Radiotherapy: A Randomized Controlled Study(REPROM) | recruiting | — | 536 | Yonsei UniversityOTHER | 1 | Sep 27, 2024 | clinicaltrials |
| NCT06608381 | Comparison Partial Versus Total Omentectomy in Minimal Invasive Distal Gastrectomy for cT3/4a Gastric Cancer (KLASS-10) | recruiting | Phase 3 | 440 | Gangnam Severance HospitalOTHER | 1 | Sep 23, 2024 | clinicaltrials |
| NCT06509724 | Comparison of Conventional and Hypofractionated IMRT in High-Risk Cervical Cancer Post-Radical Hysterectomy(POHIM-P3) | recruiting | Phase 3 | 248 | Samsung Medical CenterOTHER | 1 | Jul 26, 2024 | clinicaltrials |
| NCT06461793 | Safety of Dose Escalation in Definitive Hypofractionated Radiation Therapy and Hormone Therapy With SpaceOAR TM for Patients With High - Risk Localized Prostate Cancer (DESAR-H)(DESAR-H) | recruiting | Phase 2 | 33 | Samsung Medical CenterOTHER | 1 | Jun 21, 2024 | clinicaltrials |
| NCT06461819 | Safety of Dose Escalation in Definitive Hypofractionated Radiation Therapy With SPACEOAR TM for Patients With Low-to-intermediate Risk Localized Prostate Cancer (DESAR-L)(DESAR-L) | recruiting | Phase 2 | 33 | Samsung Medical CenterOTHER | 1 | Jun 21, 2024 | clinicaltrials |
| NCT06467097 | Systemic Treatment Alone Versus Systemic Treatment Plus Radiotherapy in Oligometastatic Renal Cell Carcinoma(SABLOR) | recruiting | Phase 3 | 88 | Samsung Medical CenterOTHER | 1 | Jun 20, 2024 | clinicaltrials |
| NCT05876130 | Postoperative Hypofractionated Intensity-modulated Radiotherapy Endometrial Cancer | recruiting | N/A | 92 | Samsung Medical CenterOTHER | 1 | Jun 12, 2024 | clinicaltrials |
| NCT05460975 | Breast Cancer Risk From Sonographic Glandular Tissue Component (or International GTC Study) | recruiting | — | 16,164 | Seoul National University HospitalOTHER | 1 | Jun 4, 2024 | clinicaltrials |
| NCT06426810 | Electrosurgical Bipolar Systems Versus Conventional Electrocautery After SLNBx | recruiting | N/A | 40 | SMG-SNU Boramae Medical CenterOTHER | 1 | May 23, 2024 | clinicaltrials |
| NCT02920554 | The Effect in Wedge Resection and IVb/V Resection of the Liver for Gallbladder Cancer | recruiting | N/A | 88 | Saint Vincent's Hospital, KoreaOTHER | 1 | May 22, 2024 | clinicaltrials |
| NCT02619890 | Brain Glioma Registry Combining Clinical and Imaging Information | recruiting | — | 9,000 | Asan Medical CenterOTHER | 1 | May 14, 2024 | clinicaltrials |
| NCT05804786 | Prospective Cohort of Diagnostic Bronchoscopy for Peripheral Lung Lesions | recruiting | — | 1,240 | Seoul National University Bundang HospitalOTHER | 1 | May 10, 2024 | clinicaltrials |
| NCT06389552 | Long-term Observational Study to Evaluate the DFS and OS of Adjuvant FOLFIRINOX Regimen in Pancreatic Cancer Patients | recruiting | — | 36 | HK inno.N CorporationINDUSTRY | 1 | Apr 29, 2024 | clinicaltrials |
| NCT06373055 | Prediction of Therapeutic Response to Neoadjuvant Chemotherapy in Muscle Invasive Bladder Cancer Patients Using Spatial Transcriptomics | recruiting | — | 250 | Yonsei UniversityOTHER | 1 | Apr 18, 2024 | clinicaltrials |
| NCT05477264 | Concurrent Tislelizumab and Radiotherapy in Newly Diagnosed Extranodal NK/T-cell Lymphoma, Nasal Type | recruiting | Phase 2 | 38 | Won Seog KimOTHER | 1 | Apr 3, 2024 | clinicaltrials |
| NCT06334471 | Whole Genome Sequencing in Breast Cancer(WGS SIT) | recruiting | — | 1,200 | Inocras Korea Inc.INDUSTRY | 1 | Apr 3, 2024 | clinicaltrials |
| NCT06326502 | A Safety and Efficacy Study of Multiple Tyrosine Kinase Inhibitor Drug (ETN101) in Advanced Hepatocellular Carcinoma | recruiting | Phase 1 | 50 | Etnova Therapeutics Corp.INDUSTRY | 1 | Mar 27, 2024 | clinicaltrials |
| NCT06330012 | The Resistance Mechanism of Trastuzumab Deruxtexan in HER2 Positive Breast Cancer Patients. | recruiting | N/A | 50 | Samsung Medical CenterOTHER | 1 | Mar 26, 2024 | clinicaltrials |
| NCT06330870 | Brain Metastasis Development Mechanism in BCBM Patients | recruiting | N/A | 30 | Samsung Medical CenterOTHER | 1 | Mar 26, 2024 | clinicaltrials |
| NCT05217407 | Marker Assisted Selective ThErapy in Rare Cancers: Knowledge Database Establishing registrY Asia(MASTERKEY ASIA) | recruiting | — | 1,000 | National Cancer Center, JapanOTHER_GOV | 7 | Mar 22, 2024 | clinicaltrials |
| NCT06265025 | GM103 Intratumoral Injection in Patients With Locally Advanced, Unresectable, Refractory and/or Metastatic Solid Tumors | recruiting | Phase 1 / Phase 2 | 125 | GeneMedicine Co., Ltd.INDUSTRY | 1 | Mar 21, 2024 | clinicaltrials |
| NCT05389956 | Identification of Risk Factors for Cardiovascular Disease and Cancer in Korean Population: A Prospective Cohort Study | recruiting | — | 510,000 | Ulsan University HospitalOTHER | 1 | Mar 19, 2024 | clinicaltrials |
| NCT01935778 | Compare Adjuvant Chemotherapy of Docetaxel/Capecitabine/Oxliplatin Versus Capecitabine/Oxaliplatin in Advanced Gastric Cancer at Stage IIIb and IV(KCSG ST15-08): TRIUMPH | recruiting | Phase 3 | 286 | Asan Medical CenterOTHER | 1 | Feb 28, 2024 | clinicaltrials |
Data updated 23 days agoSource updated unknownsource: clinicaltrials